Abstract
Six patients received 10 mg of midazolam intravenously during the anhepatic period of liver transplantation. Arterial blood was sampled during this time and for a similar period following revascularisation. The plasma was analysed using gas chromatography and electron capture detection (GC-ECD) for midazolam alpha-hydroxymidazolam and alpha-hydroxymidazolam glucuronide. Five of the six patients had small but significant concentrations of metabolites detected during the anhepatic period, demonstrating the presence of extra-hepatic sites of metabolism for this drug. The remaining patient had plasma concentrations of metabolites below the lower limit of detection (2 micrograms l-1). This may represent a pharmacogenetic abnormality or a temporary failure of midazolam metabolism secondary to the patients illness affecting the extra-hepatic sites of metabolism.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Accumulation of midazolam in patients receiving mechanical ventilation. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1309–1309. doi: 10.1136/bmj.289.6454.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown C. R., Sarnquist F. H., Canup C. A., Pedley T. A. Clinical, electroencephalographic, and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate. Anesthesiology. 1979 May;50(5):467–470. doi: 10.1097/00000542-197905000-00017. [DOI] [PubMed] [Google Scholar]
- Byatt C. M., Lewis L. D., Dawling S., Cochrane G. M. Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. Br Med J (Clin Res Ed) 1984 Sep 29;289(6448):799–800. doi: 10.1136/bmj.289.6448.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carmichael F. J., Lindop M. J., Farman J. V. Anesthesia for hepatic transplantation: cardiovascular and metabolic alterations and their management. Anesth Analg. 1985 Feb;64(2):108–116. [PubMed] [Google Scholar]
- Dundee J. W., Collier P. S., Carlisle R. J., Harper K. W. Prolonged midazolam elimination half-life. Br J Clin Pharmacol. 1986 Apr;21(4):425–429. doi: 10.1111/j.1365-2125.1986.tb05217.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dundee J. W., Samuel I. O., Toner W., Howard P. J. Midazolam: a water-soluble benzodiazepine. Studies in volunteers. Anaesthesia. 1980 May;35(5):454–458. doi: 10.1111/j.1365-2044.1980.tb03821.x. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Abernethy D. R., Locniskar A., Harmatz J. S., Limjuco R. A., Shader R. I. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984 Jul;61(1):27–35. [PubMed] [Google Scholar]
- Greenblatt D. J., Locniskar A., Ochs H. R., Lauven P. M. Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology. 1981 Aug;55(2):176–179. doi: 10.1097/00000542-198108000-00014. [DOI] [PubMed] [Google Scholar]
- Lloyd-Thomas A. R., Booker P. D. Infusion of midazolam in paediatric patients after cardiac surgery. Br J Anaesth. 1986 Oct;58(10):1109–1115. doi: 10.1093/bja/58.10.1109. [DOI] [PubMed] [Google Scholar]
- Mahon W. A., Inaba T., Stone R. M. Metabolism of flurazepam by the small intestine. Clin Pharmacol Ther. 1977 Aug;22(2):228–233. doi: 10.1002/cpt1977222228. [DOI] [PubMed] [Google Scholar]
- Shelly M. P., Mendel L., Park G. R. Failure of critically ill patients to metabolise midazolam. Anaesthesia. 1987 Jun;42(6):619–626. doi: 10.1111/j.1365-2044.1987.tb03086.x. [DOI] [PubMed] [Google Scholar]
